2026 NPPES data Nephrology Physician NPI 1699714030 DO
Verify on CMS →

MATTHEW STAINBROOK, DO

Nephrology Physician in DU BOIS, Pennsylvania. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
3K
Medicare Part D claims · 318 beneficiaries · Nephrology Physician avg: 1K
Generic prescribing
86%
generic claims · 14% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
95.0451/100
▲ 12 pts above national avg 83.1 · [object Object]
Industry payments
$1.7K
88 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MATTHEW STAINBROOK, DO reported a CMS MIPS final score of 95.0451/100 — above the 83.1 national average — and filed 2,807 Medicare Part D claims in 2023.

95.0451/100
MIPS score · +12 vs avg
3K
Part D claims, 2023
86%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MATTHEW STAINBROOK, DO's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

95 Top 21% higher than 79% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MATTHEW STAINBROOK, DO practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MATTHEW STAINBROOK, DO?

High performer (top quartile)

NPI registry status

Active

Issued 06/04/2006

NPI 1699714030

Primary specialty

Nephrology Physician

Mid-sized

10,534 US NPIs in this specialty

Medicare Part D claims

2,807 93% vs specialty avg

2023 prescription claims

Specialty avg: 1,454

MIPS final score

95.0451/100 11.94510000000001% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Pennsylvania

How Nephrology Physician compares to other specialties among Pennsylvania providers

Pennsylvania providers

Nephrology Physician share within Pennsylvania

1. Nephrology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Nephrology Physician share within Pennsylvania

Medicare quality performance — MIPS

MATTHEW STAINBROOK, DO's 2023 MIPS final score plotted against the Nephrology Physician national average

High performer (top quartile)
MIPS Final Score
95.0451/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Nephrology Physician) — 95.0451/100 vs national avg 83.1

0%100%National avg83%95%
MIPS final score (Nephrology Physician) — 95.0451/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MATTHEW STAINBROOK, DO appears in the CMS NPPES registry as a Nephrology Physician provider holding DO credentials at 190 W PARK AVE, DU BOIS, PA, 15801, with a listed phone of (814) 371-7590. NPI 1699714030 was issued on 06/04/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what STAINBROOK most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,807 prescription claims written by this provider, covering 318 Medicare beneficiaries and totaling roughly $768K in drug spend, split 14% brand-name and 86% generic by claim count, with an opioid prescribing rate of 0.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 95.0451/100 for the 2023 performance year (Quality 98.3333, Cost 69.0391), compared with the national average of 83.1.

Nephrology Physician is a mid-sized specialty nationwide, with 10,534 enrolled providers across 55 states and an average of 1,454 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

190 W PARK AVE
DU BOIS, PA 15801

Provider Details

NPI 1699714030
Specialty Nephrology Physician
Credentials DO
Gender Male
NPI Issued 06/04/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

95.0451
Final Score
Avg: 83.1
98.3333
Quality
69.0391
Cost

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MATTHEW STAINBROOK, DO. Source: openpaymentsdata.cms.gov.

Total received

$1.7K

Largest payer

Travere Therapeutics, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Pennsylvania PA-BOM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 — they are NOT specific to MATTHEW STAINBROOK, DO. To verify MATTHEW STAINBROOK, DO's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases

PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

MATTHEW STAINBROOK, DO — brand share 14.0%
Specialty average (est.)

14% brand-name claims vs 86% generic, on 2,807 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,807
Total Claims
$768K
Total Drug Cost
318
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
5,006
Total Day Supply
146,826
Brand vs Generic
14% brand / 86% generic
Brand Drug Cost
$556K
Generic Drug Cost
$211K
Opioid Claims
12 (0.4% rate)
Antibiotic Claims
63

Patient Demographics

Average Patient Age
70.9 years
Avg HCC Risk Score
4.53
Gender Split
48% female / 52% male
Age Distribution
<65: 72, 65-74: 125, 75-84: 97, 85+: 24

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MATTHEW STAINBROOK, DO prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Valsartan
182
Sevelamer Carbonate
150
Allopurinol
119
Midodrine Hcl
103
Carvedilol
102
Bumetanide
96
Amlodipine Besylate
94
Atorvastatin Calcium
88
Clonidine
81
Levothyroxine Sodium
80

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Nephrology Physician Overview

How MATTHEW STAINBROOK, DO fits within the Nephrology Physician landscape nationally.

10,534
Nephrology Physician Providers in US
55
States with Nephrology Physician
1,454
Avg Claims per Provider

MATTHEW STAINBROOK, DO's 2,807 claims are above the specialty average of 1,454.

Nearby Nephrology Physician Providers in Pennsylvania

Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as STAINBROOK.

Compare Nephrology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MATTHEW STAINBROOK, DO's specialty?
MATTHEW STAINBROOK, DO specializes in Nephrology Physician and practices in DU BOIS, Pennsylvania. Credentials: DO.
How much does MATTHEW STAINBROOK, DO prescribe under Medicare Part D?
In 2023, MATTHEW STAINBROOK, DO wrote 2,807 Medicare Part D claims totaling $768K in drug costs for 318 beneficiaries.
What is MATTHEW STAINBROOK, DO's Medicare quality score?
MATTHEW STAINBROOK, DO has a CMS MIPS Final Score of 95.0451/100 (Quality: 98.3333, Cost: 69.0391). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MATTHEW STAINBROOK, DO located?
MATTHEW STAINBROOK, DO is located at 190 W PARK AVE, DU BOIS, PA, 15801. Phone: (814) 371-7590.
What is MATTHEW STAINBROOK, DO's NPI number?
MATTHEW STAINBROOK, DO's National Provider Identifier (NPI) is 1699714030, issued on 06/04/2006.
Does MATTHEW STAINBROOK, DO prescribe more brand-name or generic drugs?
MATTHEW STAINBROOK, DO's prescribing is 14% brand-name and 86% generic drugs by claim count, with $556K in brand drug costs.
Does MATTHEW STAINBROOK, DO prescribe opioids?
Yes, MATTHEW STAINBROOK, DO had 12 opioid claims in 2023 with an opioid prescribing rate of 0.4%.
How many Nephrology Physician providers are there in the US?
There are 10,534 Nephrology Physician providers across 55 states in the US. The average Nephrology Physician provider writes 1,454 Medicare Part D claims per year.
What drugs does MATTHEW STAINBROOK, DO prescribe most often?
Based on 2023 Medicare Part D data, MATTHEW STAINBROOK, DO's most frequently prescribed drugs include Valsartan, Sevelamer Carbonate, Allopurinol. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MATTHEW STAINBROOK, DO accept Medicare?
MATTHEW STAINBROOK, DO appears in CMS Medicare data with 2,807 Part D claims and 318 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MATTHEW STAINBROOK, DO's credentials?
MATTHEW STAINBROOK, DO's NPI is 1699714030 with credentials DO. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology